Heart Failure Epidemiology Forecast Report 2021-2030 – Focus on United States, Germany, France, Italy, Spain, United Kingdom and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Heart Failure – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

This ‘Heart Failure (HF) – Epidemiology Forecast-2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Heart Failure (HF) Epidemiology Perspective

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Population of HF, Diagnosed Prevalent Population of HF, Gender-specific diagnosed prevalent cases of HF, Age-specific diagnosed prevalent cases of HF, NYHA class-specific diagnosed prevalent cases of HF, Diagnosed prevalent cases of HF with Ejection Fraction, Diagnosed Prevalent cases of HF associated with comorbidities scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2018 to 2030.

Heart Failure Detailed Epidemiology Segmentation

• Total Diagnosed Prevalent Cases of Heart Failure (HF) in the 7MM was found to be 12,602,028 in 2020, which is expected to grow during the study period (2018-2030).
• Among 7MM, the United States has the highest diagnosed prevalent population of HF, i.e., 5,163,119 cases in 2020, which is 40.97% of the total diagnosed cases of HF in the 7MM.
• In EU-5, Germany has the highest number of diagnosed cases, i.e., 2,216,497 followed by Spain with 1,283,827 cases and Italy with 1,164,031 cases. While, UK has the least number of cases with 728,547 in 2020.
• There are several Heart Failure related comorbidities which include obesity, hyperlipidemia, metabolic syndrome, and others. Amongst them in the US, in 2020, 3,837,746, 2,237,179, 991,319, 1,626,382, 1,587,659, 3,097,871, and 2,065,247 cases were observed in Hypertension, Diabetes Mellitus, Chronic Kidney Disease, Atrial Fibrillation, COPD, Ischemic heart disease, and Dilated cardiomyopathy.
• Age-specific data shows that the diagnosed prevalent cases are seen maximum in elderly patients (? 85 age) this is due to the progressive aging of the population as well as improved and better survival after cardiac insults, such as myocardial infarction, especially in developed countries.
• Heart failure is an important cause of morbidity and mortality in women, and the patients tend to develop it at an older age. According to the analysis, in 2020, the estimated cases of HF were 2,478,297 in males and 2,684,822 in females, in the US.

Scope of the Report

• The report covers the descriptive overview of HF, explaining its causes, symptoms, pathophysiology, and genetic basis.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of HF.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM by Prevalent Population of HF, Diagnosed Prevalent Population of HF, Gender-specific diagnosed prevalent cases of HF, Age-specific diagnosed prevalent cases of HF, NYHA class-specific diagnosed prevalent cases of HF, Diagnosed prevalent cases of HF with Ejection Fraction, and Diagnosed Prevalent cases of HF associated with comorbidities.

Report Highlights

• 10-Year Forecast of HF
• 7MM Coverage
• Total Prevalent Cases of HF
• Diagnosed Prevalent Cases of HF
• Gender-specific Cases of HF
• Age-specific Cases of HF
• NYHA Class-specific diagnosed prevalence of HF
• Diagnosed prevalent cases of Heart Failure with Ejection Fraction
• Diagnosed Prevalent cases of Heart Failure associated with comorbidities in the

Key Questions Answered

• What are the disease risk, and burden of HF ?
• What is the historical HF patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of HF at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to HF ?
• Out of the above-mentioned countries, which country would have the highest prevalent population of HF during the forecast period (2021-2030)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2021-2030)?

Reasons to Buy

• Develop business strategies by understanding the trends shaping and driving the 7MM HF epidemiology forecast.
• The HF epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The HF epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

For more information about this report visit https://www.researchandmarkets.com/r/10vvvq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900